| Product ID |
Product Name |
CAS# |
Purity |
| Y1339893 |
4-bromopyridin-3,5,6-d3-2-amine |
1643564-94-6 |
98% |
| Y3288440 |
KIRA-7 |
1937235-76-1 |
98% |
| Y1238607 |
NCGC00229600 |
1338824-20-6 |
99% |
| Y3295592 |
DI-87 |
2107280-55-5 |
98% |
| Y3106549 |
4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1H-pyrazole |
2096995-02-5 |
95% |
| Y3106550 |
2-methylimidazo[2,1-b][1,3]thiazole-6-carboxylic acid |
1038361-67-9 |
95% |
| Y1238702 |
[1,1'-binaphthalene]-2,2'-diylbis(diphenylphosphine oxide) |
86632-33-9 |
98% |
| Y3116514 |
5-(5-chloro-2-(trifluoromethyl)phenyl)oxazole |
2364584-97-2 |
95% |
| Y3106565 |
3-oxa-9-thiaspiro[5.5]undecane-2,4-dione |
2322694-92-6 |
95% |
| Y3112082 |
9-(pyrrolidin-3-yl)-9H-purin-6-amine dihydrochloride |
898828-81-4 |
95% |
| Y3112052 |
2,3-Dihydro-N-methyl-N-[2-oxo-2-[(2,3,4-trifluorophenyl)amino]ethyl]-1,4-benzodioxin-6-carboxamide |
870768-70-0 |
99% |
| Y3298150 |
4-(6-Nitro-quinolin-4-ylamino)-N-[4-(pyridin-4-ylamino)-phenyl]-benzamide |
50440-30-7 |
99% |
| Y3294638 |
PU-139;2-(4-Fluorophenyl)isothiazolo[5,4-b]pyridin-3(2H)-one |
158093-65-3 |
99% |
| Y3118494 |
EH-IDTBr |
2102510-60-9 |
99% |
| Y1238631 |
4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide |
942195-86-0 |
98% |
| Y1234316 |
3-(Bromomethyl)-6-(trifluoromethyl)pyridazine |
1173897-85-2 |
95% |
| Y1234347 |
(R)-1,1-Difluoropropan-2-amine hydrochloride |
1018434-72-4 |
95% |
| Y1083543S |
4-(1-Amino-2-hydroxyethyl)phenol hydrochloride |
146812-69-3 |
95% |
| Y1338618 |
2-[3-(1,1-dimethylethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-phenylpyridine |
2411987-38-5 |
98% |
| Y1335580 |
4,4,5,5-tetramethyl-2-(1,2,2-triphenylvinyl)-1,3,2-dioxaborolane |
219488-97-8 |
98% |
| Y3118526 |
3,4-Dibromo-2-fluorobenzoic acid |
1804416-86-1 |
95% |
| Y1238653 |
S-isopropyl O-methyl thiocarbonate |
38103-97-8 |
95%+ |
| Y1234365 |
TM6089 |
863421-32-3 |
99% |
| Y3250906 |
AHR antagonist 5 |
2247953-39-3 |
98% |
| Y3292393 |
IRE1a kinase-IN-2 |
1414938-21-8 |
98% |
| Y3306193 |
20-HEDE |
240427-90-1 |
95% |
| Y3114844 |
tert-Butyl (3-(3-aminopropoxy)propy l)carbamate |
848419-01-2 |
95% |
| Y1238671 |
4-Amino-N-(5-chloro-2-methylphenyl)benzamide |
897595-52-7 |
97% |
| Y3114841 |
3-(2,5-dioxo-2,5-dihydrofuran-3-yl)propanoic acid |
131548-97-5 |
95% |
| Y3317637 |
3-(tert-Butyl)-5-(dimethylamino)-2-hydroxybenzaldehyde |
335596-75-3 |
95% |
| Y3316392 |
Ethyl 5-aminobenzo[d]oxazole-2-c arboxylate |
1159515-88-4 |
95% |
| Y3113069 |
Benzoic acid, 4-hydroxy-, 4-nitrophenyl ester |
38597-39-6 |
97% |
| Y3113740 |
Bicyclo[2.1.0]pentane-2-carboxylic acid |
2247102-46-9 |
95% |
| Y1300824 |
2-Chloro-1,7-dihydro-1-methyl-7-(phenylmethyl)-6H-purin-6-one |
140379-24-4 |
95% |
| Y1247485 |
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
571189-65-6 |
97% |
| Y3111999 |
CC-17368 |
1547162-41-3 |
95% |
| Y3315296 |
ELA-21 (human) |
2245073-05-4 |
98.92% |
| Y3118545 |
methylene calcitriol |
1428946-52-4 |
95%+ |
| Y1347149 |
Axitinib Impurity 2 |
1428728-83-9 |
95% |
| Y3317377 |
4H-1-Benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-3-[(4-methoxyphenyl)methyl |
118204-64-1 |
98% |
| Y3111981 |
1-[(1r,4r)-4-(trifluoromethyl)cyclohexyl]methanamine hydrochloride, trans |
2503204-92-8 |
95% |
| Y1326380 |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
1038972-16-5 |
95% |
| Y1247486 |
2,2-bis(hydroxymethyl)propane-1,3-diyl bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate) |
36913-60-7 |
95% |
| Y1251694 |
Chitinase-IN-2 hydrochloride |
2070014-83-2 |
99% |
| Y3305201 |
NSC 601980 |
2070018-27-6 |
98.11% |
| Y1251705 |
Pimelic Diphenylamide 106 (analog) |
2070015-24-4 |
96% |
| Y3119019 |
Venetoclax N-oxide |
2469279-00-1 |
98% |
| Y1247487 |
DB04760 analog 1 |
2728373-94-0 |
99% |
| Y3308456 |
Relamorelin |
661472-41-9 |
98% |
| Y1296497 |
Methyl(4-(trifluoromethyl)phenyl)carbamic chloride |
1235712-89-6 |
95% |
| Y1251695 |
Isopropyl phenyl carbonate |
943-57-7 |
95% |
| Y1313406 |
4-METHYL-1-(4-NITROPHENYL)PIPERIDIN-4-OL |
1002726-90-0 |
96% |
| Y3118889 |
5-NITROPYRIMIDINE-2,4,6-TRIOL |
106351-49-9 |
95% |
| Y1338328 |
2',5'-Difluoro-[1,1':4',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid |
1119195-97-9 |
97% |
| Y1247427 |
1-bromo-2-methyl-4-nitronaphthalene |
10317-70-1 |
95% |
| Y1344333 |
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, compd. with methanesulfonate (1:2) |
2070014-82-1 |
99% |
| Y3292036 |
Imidodicarbonimidic diamide, N,N-dimethyl-, hydrochloride (1:2) |
1674364-49-8 |
97% |
| Y3316613 |
Ethyl 7-hydroxypyrazolo[1,5-a]pyrimidine-5-carboxylate |
1174064-69-7 |
95% |
| Y3311309 |
Barite |
13462-86-7 |
AR,99% |
| Y3122765 |
2H-Thieno[2,3-c]pyrrole, hexahydro-3-methoxy-, 1,1-dioxide, (3R,3aS,6aR)-rel- |
1955547-56-4 |
95% |
| Y3122739 |
(-)-trans-Permethrin |
54774-47-9 |
99% |
| Y3122754 |
Pyridine, 4-hydrazinyl-3-methyl-, hydrochloride (1:2) |
2097938-62-8 |
95% |
| Y3114583 |
rel-(1R,2S)-2-Phenylcyclopropaneacetonitrile |
54322-67-7 |
95% |
| Y3113067 |
Lead oxide sulfate (Pb4O3(SO4)) |
12202-17-4 |
99% |
| Y3306838 |
Ribulose 1,5-bisphosphate |
24218-00-6 |
90% |
| Y3317171 |
Akaganeite |
12134-57-5 |
Fe50% |
| Y3114655 |
Cinnamic acid, ß-ethyl-p-methoxy-, (E)- |
30219-42-2 |
95% |
| Y1243879 |
(S)-1-(6-bromopyridin-2-yl)-2,2,2-trifluoroethanamine hydrochloride |
1213555-42-0 |
95% |
| Y1243999 |
(2R,3R,4S,5R)-2-(acetoxymethyl)-6-fluorotetrahydro-2H-pyran-3,4,5-triyl triacetate |
162489-61-4 |
96% |
| Y1244012 |
6-((2-chloro-5-fluoropyrimidin-4-yl)amino)-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one |
575473-90-4 |
97% |
| Y1243982 |
(2S,4R)-N-(2,6-Dimethylphenyl)-4-hydroxypyrrolidine-2-carboxamide |
2227488-62-0 |
95% |
| Y3305863 |
HM-30181 mesylate monohydrate |
2097125-58-9 |
98% |
| Y3306698 |
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide |
1404117-65-2 |
96% |
| Y3113078 |
WH-4-025 |
1876463-35-2 |
95% |
| Y3308371 |
GW406108X(Z/E) |
265098-01-9 |
99% |
| Y1243984 |
DBCO-(CH2)3-Acid |
1207355-31-4 |
95% |
| Y3292337 |
Simufilam dihydrochloride |
2480226-06-8 |
95% |
| Y3112111 |
NCGC00378430 |
920650-00-6 |
99% |
| Y3307869 |
Spautin-1 |
1262888-20-9 |
100% |
| Y3306512 |
HC067047 Hydrochloride(883031-03-6 free base) |
1481646-76-7 |
99% |
| Y3307823 |
5-TAMRA chloride(91809-66-4 free base) |
125481-77-8 |
99% |
| Y3308791 |
BIM-46187 4HCl |
2489449-03-6 |
99% |
| Y3114563 |
ABT-384 |
868623-40-9 |
99% |
| Y3304580 |
Cefalonium Dihydrate(5575-21-3 free base) |
1385046-35-4 |
95% |
| Y1244000 |
1,3-Dioxolane,2-(3,5-dibromophenyl)- |
773094-77-2 |
>98% |
| Y1248355 |
5-Hexyl-2,4-dihydroxyisophthalaldehyde |
1421703-19-6 |
97% |
| Y3295460 |
Hex |
2004714-32-1 |
99% |
| Y3308977 |
PD-1-IN-24 |
2360909-50-6 |
98.04% |
| Y3246056 |
2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethanamine hydrochloride |
502180-66-7 |
95% |
| Y1244014 |
4-Hydroxy -1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline |
2408830-96-4 |
95%+ |
| Y1305013 |
2-tert-butyl 3-methyl 2,5-diazabicyclo[2.2.2]octane-2,3-dicarboxylate |
2231673-16-6 |
95% |
| Y3114670 |
3-bromo-N-methyl-1,2,4-thiadiazol-5-amine |
1824463-29-7 |
95% |
| Y3114682 |
2-chloro-4,5,6-trimethylpyrimidine |
24307-77-5 |
95% |
| Y1248361 |
N,N-dibenzyl-1,3-dimethoxypropan-2-amine |
1156542-80-1 |
97% |
| Y3287102 |
4,7,10,13,16,19-Docosahexaenoic acid, 2,3-dihydroxypropyl ester,(4Z,7Z,10Z,13Z,16Z,19Z)- |
140670-40-2 |
98% |
| Y3290802 |
L-Alpha-Lysophosphatidylcholine,oleoyl-d7 |
2097561-13-0 |
99% |
| Y3312026 |
diABZI STING agonist-3 |
2138498-18-5 |
99% |
| Y3292411 |
AZD9898 |
2042347-69-1 |
98% |
| Y3307512 |
JAK-IN-1 |
1334673-53-8 |
99.44% |
| Y3308120 |
TH-263 |
313520-94-4 |
99% |